These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1698137)

  • 1. Short-term effects of diethylaminoethyl-dextran on postprandial gastrointestinal hormone responses in man.
    Soldani G; Della Longa A; Mengozzi G; Demi S; Intorre L; Martelli F
    Drugs Exp Clin Res; 1990; 16(2):67-73. PubMed ID: 1698137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of pirenzepine on meal-stimulated gastrointestinal hormones.
    El-Sabbagh HN; Bloom SR; Adrian TE; Prinz RA; Baron JH; Welbourn RB
    Scand J Gastroenterol Suppl; 1980; 66():57-61. PubMed ID: 6113682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meal frequency; does it determine postprandial lipaemia?
    Murphy MC; Chapman C; Lovegrove JA; Isherwood SG; Morgan LM; Wright JW; Williams CM
    Eur J Clin Nutr; 1996 Aug; 50(8):491-7. PubMed ID: 8863008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of gut hormone responses to feeding in neonates.
    Lucas A; Bloom SR; Aynsley-Green A
    Arch Dis Child; 1980 Sep; 55(9):678-82. PubMed ID: 7192077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postprandial mesenteric blood flow in humans: relationship to endogenous gastrointestinal hormone secretion and energy content of food.
    Parker DR; Carlisle K; Cowan FJ; Corrall RJ; Read AE
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):435-40. PubMed ID: 7614106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemistry and pharmacology of diethylaminoethyl-dextran (DEAE-D).
    Soldani G; Maccheroni M; Martelli F; Mengozzi G; Cardini G
    Int J Obes; 1987; 11 Suppl 3():201-7. PubMed ID: 2450070
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of the pathway of bile flow on the digestion of fat and the release of gastrointestinal hormones.
    Imamura M; Takahashi M; Sasaki I; Yamauchi H; Sato T
    Am J Gastroenterol; 1988 Apr; 83(4):386-92. PubMed ID: 3279758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vasoactive intestinal polypeptide in obesity.
    Tomkin GH; Ardill J; Lafferty H; Darragh A
    Int J Obes; 1983; 7(2):153-60. PubMed ID: 6345422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postnatal surges in plasma gut hormones in term and preterm infants.
    Lucas A; Bloom SR; Aynsley-Green A
    Biol Neonate; 1982; 41(1-2):63-7. PubMed ID: 6802191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric acid secretion and gastrin and gastric inhibitory polypeptide release in cirrhotic patients.
    Sato T; Imamura M; Sasaki I; Ohneda A
    Am J Gastroenterol; 1985 Mar; 80(3):163-9. PubMed ID: 3883751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of modified sham feeding on plasma polypeptide (CCK, gastrin, motilin, neurotensin and somatostatin) concentrations in duodenal ulcer disease.
    Järhult J; Graffner H; Bloom SR
    Acta Chir Scand; 1984; 150(2):141-4. PubMed ID: 6144225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of a test meal on plasma gastric inhibitory polypeptide and serum gastrin in patients with achlorhydria and hypergastrinemia, and in patients with normal gastric H+ secretion.
    Jorde R; Burhol PG; Waldum HL
    Digestion; 1981; 21(6):304-9. PubMed ID: 7250551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult cystic fibrosis: postprandial response of gut regulatory peptides.
    Allen JM; Penketh AR; Adrian TE; Lee YC; Sarson DL; Hodson ME; Batten JC; Bloom SR
    Gastroenterology; 1983 Dec; 85(6):1379-83. PubMed ID: 6628932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurotensin infusion in man: pharmacokinetics and effect on gastrointestinal and pituitary hormones.
    Blackburn AM; Fletcher DR; Adrian TE; Bloom SR
    J Clin Endocrinol Metab; 1980 Dec; 51(6):1257-61. PubMed ID: 7002947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of gastric inhibitory polypeptide in normal and duodenal ulcer patients.
    Cataland S; O'Dorisio TM; Brooks R; Mekhjian HS
    Gastroenterology; 1977 Jul; 73(1):19-22. PubMed ID: 863190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
    Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
    J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating gastrointestinal hormones in patients with flatulent dyspepsia, with and without gallbladder disease.
    Watson RG; Shaw C; Buchanan KD; Love AH
    Digestion; 1986; 35(4):211-6. PubMed ID: 3545953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential incretins.
    Shuster LT; Go VL; Rizza RA; O'Brien PC; Service FJ
    Mayo Clin Proc; 1988 Aug; 63(8):794-800. PubMed ID: 3294522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of galanin on canine plasma glucose and gastroenteropancreatic hormone responses to oral nutrients and intravenous arginine.
    McDonald TJ; Dupre J; Greenberg GR; Tepperman F; Brooks B; Tatemoto K; Mutt V
    Endocrinology; 1986 Nov; 119(5):2340-5. PubMed ID: 2429832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased gastric inhibitory polypeptide levels in patients with symptomatic postprandial hypoglycemia.
    Hadji-Georgopoulos A; Schmidt MI; Elahi D; Hershcopf R; Kowarski AA
    J Clin Endocrinol Metab; 1983 Apr; 56(4):648-52. PubMed ID: 6339535
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.